PLoS Pathogens (Mar 2023)

Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization.

  • Grant Eilers,
  • Kushol Gupta,
  • Audrey Allen,
  • Saira Montermoso,
  • Hemma Murali,
  • Robert Sharp,
  • Young Hwang,
  • Frederic D Bushman,
  • Gregory Van Duyne

DOI
https://doi.org/10.1371/journal.ppat.1011097
Journal volume & issue
Vol. 19, no. 3
p. e1011097

Abstract

Read online

HIV integrase (IN) inserts viral DNA into the host genome and is the target of the strand transfer inhibitors (STIs), a class of small molecules currently in clinical use. Another potent class of antivirals is the allosteric inhibitors of integrase, or ALLINIs. ALLINIs promote IN aggregation by stabilizing an interaction between the catalytic core domain (CCD) and carboxy-terminal domain (CTD) that undermines viral particle formation in late replication. Ongoing challenges with inhibitor potency, toxicity, and viral resistance motivate research to understand their mechanism. Here, we report a 2.93 Å X-ray crystal structure of the minimal ternary complex between CCD, CTD, and the ALLINI BI-224436. This structure reveals an asymmetric ternary complex with a prominent network of π-mediated interactions that suggest specific avenues for future ALLINI development and optimization.